Financials

  • Market Capitalization 270.68 M
  • Employee 86
  • Founded 2014
  • CEO N/A
  • Website www.sab.bio
  • Headquarter Delaware, United States
  • FIGI BBG00YHY0G24
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.6
ratio cours/chiffre d'affaires
966.37

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3381
TTRX
Turn Therapeutics Inc. - Common Stock
9.64 USD+1.80%+2.77%+47.85%-3.60%287.16 M USD
3396
GLSI
Greenwich LifeSciences, Inc. - Common stock
19.01 USD0.00%+2.15%-17.49%+87.66%279.03 M USD
3411
MGNX
MacroGenics, Inc. - Common Stock
4.21 USD-1.86%-11.18%+1.45%+180.67%267.60 M USD
3414
IKT
Inhibikase Therapeutics, Inc. - Common Stock
2.07 USD+0.49%-0.48%+23.95%+15.00%273.31 M USD

Nouvelles